Bitcoin
63179.27
-785.19
-1.24%
Crude Oil
83.27
+1.22
+1.47%
Gold
4425.9
-20.2
-0.46%
Copper
6.63
-0.01
-0.1%
Silver
64.78
-1.27
-1.95%
Dow Jones
53975.98
-60.95
-0.11%
SP500
7725.58
-27.53
-0.36%
NASDAQ
26605.36
-85.26
-0.32%

CheckMan Stock Market Overview

Trending Stocks

Name and Ticker
Last
% Change
% Change and Signal
Volume
Signal
28.58
+99.00%
Top Gainers
1,630,860
Top Gainers
2670
+80.00%
Top Gainers
857,090
Top Gainers
5.16
+50.00%
Top Gainers
465,685
Top Gainers
2.84
+41.90%
Top Gainers
323,019
Top Gainers
19.43
+39.37%
Top Gainers
518,559
Top Gainers
3.08
+29.55%
Top Gainers
185,931
Top Gainers
3.86
+29.02%
Top Gainers
118,875
Top Gainers
2.855
+27.50%
Top Gainers
2,669,559
Top Gainers
1.32
+27.35%
Top Gainers
677,960
Top Gainers
4080
+23.04%
Top Gainers
560,012
Top Gainers

Red List

Name and Ticker
Last
% Change
% Change and Signal
Volume
Signal
16.29
-314.98%
Top Loosers
353,085
Top Loosers
1.17
-122.22%
Top Loosers
120,000
Top Loosers
45.6
-100.50%
Top Loosers
5,225,277
Top Loosers
5.5
-94.00%
Top Loosers
604,695
Top Loosers
82700
-81.02%
Top Loosers
763,022
Top Loosers
1.25
-61.60%
Top Loosers
103,615
Top Loosers
5.85
-53.50%
Top Loosers
2,825,916
Top Loosers
20.96
-50.62%
Top Loosers
229,459
Top Loosers
2.6
-47.31%
Top Loosers
924,078
Top Loosers
1.535
-45.93%
Top Loosers
182,468
Top Loosers

In Today's Headlines

Meta Platforms: The Most Disrespected Name In Big Tech
03:00
11 Aug 2026
Meta Platforms: The Most Disrespected Name In Big Tech

Meta Platforms remains my top market pick, with the market undervaluing its dominant ad business and AI optionality. META trades at just 19x earnings and 6x sales, despite 28% YoY revenue growth and robust Family of Apps margins. Heavy CapEx for AI/data centers has depressed free cash flow, but management can pivot if AI monetization lags expectations.

Guardant Health: Screening And MRD Are Just Getting Started
02:59
11 Aug 2026
Guardant Health: Screening And MRD Are Just Getting Started

Guardant Health is experiencing robust growth, driven by its MRD and screening businesses. Recent FDA approvals, expanded reimbursement, and inclusion in clinical guidelines should help to ensure growth remains strong going forward. Competition in both screening and MRD monitoring is set to intensify in coming years, though.

Archer Aviation: Takeoff Has Only Just Started
02:58
11 Aug 2026
Archer Aviation: Takeoff Has Only Just Started

Archer Aviation Inc. remains a Buy as commercialization nears. A strong financial foundation allows them to execute. TAM is growing via new military (Thunder) and commercial (Halo) platforms, plus a strategic Boeing deal for R&D synergies. FAA regulatory momentum and infrastructure initiatives position Archer Aviation for accelerated commercial deployment and long-term growth.

DPC Holdings PLC (DPC) Q2 2026 Earnings Call Transcript
02:57
11 Aug 2026
DPC Holdings PLC (DPC) Q2 2026 Earnings Call Transcript

DPC Holdings PLC (DPC) Q2 2026 Earnings Call Transcript

Honeywell Slides 5% As Future Growth Guidance At Chicago Investor Event Dissapoints
02:55
11 Aug 2026
Honeywell Slides 5% As Future Growth Guidance At Chicago Investor Event Dissapoints

Shares of Honeywell (NASDAQ:HON | HON Price Prediction) are trading sharply lower Tuesday afternoon, down roughly 4.7% to $231.49 around 2:00 p.m.

M&T Bank Rallies Nearly 20% in 3 Months: Hold or Fold the Stock Now?
02:55
11 Aug 2026
M&T Bank Rallies Nearly 20% in 3 Months: Hold or Fold the Stock Now?

Can MTB's strong revenue growth, acquisitions and capital returns sustain its momentum after a 20.3% three-month gain? Let us discuss.

Is Cisco Systems Stock Poised for New Highs as Q4 Earnings Approach?
02:51
11 Aug 2026
Is Cisco Systems Stock Poised for New Highs as Q4 Earnings Approach?

Cisco Systems (CSCO) is set to report its fiscal fourth-quarter results after the closing bell on Wednesday, Aug. 12, putting the networking giant back in the spotlight as investors assess whether its impressive momentum can continue.

Regenxbio's Multi-Catalyst Setup Is Hard To Ignore (Rating Upgrade)
02:50
11 Aug 2026
Regenxbio's Multi-Catalyst Setup Is Hard To Ignore (Rating Upgrade)

Regenxbio Inc. delivered a strong quarter, driven by milestone revenue, with GAAP EPS of $0.43 and revenue up 407% YoY. RGNX now holds $313 million in pro forma cash, funding operations into Q4 2027 and removing near-term financing overhang. Multiple late-stage catalysts—including RGX-202, pivotal wet AMD data, and RGX-121 resubmission—are stacked over the next 12–18 months.

Google's Gemini app surges to one billion users
02:49
11 Aug 2026
Google's Gemini app surges to one billion users

In a significant milestone for Google, CEO Sundar Pichai announced via X that the Gemini app has become one of the company's fastest-growing products, recently surpassing 1 billion monthly active users. Pichai also noted it was the 14th Google product to hit the 1 billion mark.

HUB GROUP DEADLINE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Hub Group, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - HUBG
02:49
11 Aug 2026
HUB GROUP DEADLINE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Hub Group, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - HUBG

New York, New York--(Newsfile Corp. - August 11, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of purchasers of securities of Hub Group, Inc. (NASDAQ: HUBG) between April 28, 2023 and May 11, 2026, inclusive (the "Class Period"), of the important August 28, 2026 lead plaintiff deadline. SO WHAT: If you purchased Hub Group securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.